<SEC-DOCUMENT>0001193125-21-049397.txt : 20210222
<SEC-HEADER>0001193125-21-049397.hdr.sgml : 20210222
<ACCEPTANCE-DATETIME>20210219214101
ACCESSION NUMBER:		0001193125-21-049397
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20210219
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210222
DATE AS OF CHANGE:		20210219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tilray, Inc.
		CENTRAL INDEX KEY:			0001731348
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38594
		FILM NUMBER:		21658088

	BUSINESS ADDRESS:	
		STREET 1:		1100 MAUGHAN ROAD
		CITY:			NANAIMO
		STATE:			A1
		ZIP:			V9X 1J2
		BUSINESS PHONE:		2064329325

	MAIL ADDRESS:	
		STREET 1:		1100 MAUGHAN ROAD
		CITY:			NANAIMO
		STATE:			A1
		ZIP:			V9X 1J2
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d64377d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:tlry="http://www.tilray.com/20210219" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:srt-types="http://fasb.org/srt/2020-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2021-02-19_to_2021-02-19" name="dei:AmendmentFlag" contextRef="duration_2021-02-19_to_2021-02-19">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2021-02-19_to_2021-02-19" name="dei:EntityCentralIndexKey" contextRef="duration_2021-02-19_to_2021-02-19">0001731348</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="tlry-20210219.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-02-19_to_2021-02-19"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001731348</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-19</xbrli:startDate> <xbrli:endDate>2021-02-19</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-02-19_to_2021-02-19">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-02-19_to_2021-02-19" format="ixt:datemonthdayyearen">February 19, 2021</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:EntityRegistrantName">Tilray, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:EntityFileNumber">001-38594</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:EntityTaxIdentificationNumber">82-4310622</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br />of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br />Identification No.)</span></td></tr> </table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:EntityAddressAddressLine1">1100 Maughan Rd</ix:nonNumeric>.,</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:EntityAddressCityOrTown">Nanaimo</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:EntityAddressStateOrProvince">BC</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen">Canada</ix:nonNumeric></p></td>
<td style="vertical-align:bottom"> </td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom"> </td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:EntityAddressPostalZipCode">V9X 1J2</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: (<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-02-19_to_2021-02-19">844</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-02-19_to_2021-02-19">845-7291</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-02-19_to_2021-02-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-02-19_to_2021-02-19" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-02-19_to_2021-02-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr> </table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:35%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:31%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-02-19_to_2021-02-19">Class&#160;2 Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:TradingSymbol">TLRY</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2021-02-19_to_2021-02-19" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr> </table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#160;240.12b-2 of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-02-19_to_2021-02-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top"><span style="font-weight:bold">Item&#160;1.01.</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Agreement.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="text-decoration:underline">Arrangement Agreement Amendment </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed on December&#160;15, 2020, Tilray, Inc., a Delaware corporation (&#8220;Tilray&#8221;), and Aphria Inc., a corporation existing under the laws of the Province of Ontario (&#8220;Aphria&#8221;), entered into an Arrangement Agreement (the &#8220;Arrangement Agreement&#8221;), pursuant to which all of the issued and outstanding common shares of Aphria (the &#8220;Aphria Shares&#8221;) will be exchanged for Class&#160;2 common stock of Tilray, in accordance with a specified exchange ratio, pursuant to a plan of arrangement (the &#8220;Plan of Arrangement&#8221;) under the Business Corporations Act (Ontario) (the &#8220;Arrangement&#8221;).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February 19, 2021, Tilray and Aphria entered into an amendment to the Arrangement Agreement and Plan of Arrangement (the &#8220;Amendment&#8221;). The Amendment, among other things: (i) provides that Aphria will convene and conduct the Aphria Meeting in connection with the Arrangement, as promptly as reasonably practicable (and in any event not later than June 30, 2021); (ii) provides that Tilray will convene and conduct the Tilray Meeting in connection with the Arrangement, as promptly as reasonably practicable (and in any event not later than June 30, 2021); (iii) provides that certain holders of Aphria&#8217;s outstanding restricted share units or deferred share units and certain holders of options to acquire Aphria Shares will not exchange such securities for replacement securities issued by Tilray pursuant to the Plan of Arrangement but will continue to hold such securities in accordance with the applicable terms of the Aphria Benefit Plans (as defined in the Arrangement Agreement). Pursuant to the provisions of the Aphria Benefit Plans, such securities will be settled or exercisable, as applicable, for Tilray Shares in accordance with their terms following the completion of the Arrangement; (iv) clarifies the requisite approval of Tilray stockholders required to complete the Arrangement, in accordance with the Arrangement Agreement and (v) makes certain corresponding edits to the Arrangement Agreement to implement the foregoing.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than as expressly modified pursuant to the Amendment, the Arrangement Agreement and the Plan of Arrangement remain in full force and effect as originally executed as of December&#160;15, 2020. The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is filed as Exhibit 2.1 hereto and incorporated herein by reference.</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Additional Information and Where to Find It</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the proposed transaction, Aphria will file a management information circular, and Tilray will file a proxy statement on Schedule 14A containing important information about the proposed transaction and related matters. Additionally, Aphria and Tilray will file other relevant materials in connection with the proposed transaction with the applicable securities regulatory authorities. Investors and security holders of Aphria and Tilray are urged to carefully read the entire management information circular and proxy statement (including any amendments or supplements to such documents), respectively, when such documents become available before making any voting decision with respect to the proposed transaction because they will contain important information about the proposed transaction and the parties to the transaction. The Aphria management information circular and the Tilray proxy statement will be mailed to the Aphria and Tilray shareholders, respectively, as well as be accessible on the SEDAR and EDGAR profiles of the respective companies.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors and security holders of Tilray will be able to obtain a free copy of the proxy statement, as well as other relevant filings containing information about Tilray and the proposed transaction, including materials that will be incorporated by reference into the proxy statement, without charge, at the SEC&#8217;s website (www.sec.gov) or from Tilray by contacting Tilray&#8217;s Investor Relations at (203) <span style="white-space:nowrap">682-8253,</span> by email at Raphael.Gross@icrinc.com, or by going to Tilray&#8217;s Investor Relations page on its website at https://ir.tilray.com/investor-relations and clicking on the link titled &#8220;Financials.&#8221;</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Participants in the Solicitation</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tilray and Aphria and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of Tilray proxies in respect of the proposed transaction. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to Tilray stockholders in connection with the proposed transaction will be set forth in the Tilray proxy statement for the proposed transaction when available. Other information regarding the participants in the Tilray proxy solicitation and a description of their direct and indirect interests in the proposed transaction, by security holdings or otherwise, will be contained in such proxy statement and other relevant materials to be filed with the SEC in connection with the proposed transaction. Copies of these documents may be obtained, free of charge, from the SEC or Tilray as described in the preceding paragraph.</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Notice Regarding Forward-Looking Statements</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain information in this communication constitutes forward-looking information or forward-looking statements (together, &#8220;forward-looking statements&#8221;) under Canadian securities laws and within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbor created by such sections and other applicable laws. The forward-looking statements are expressly qualified by this cautionary statement. Any information or statements that are contained in this communication that are not statements of historical fact may be deemed to be forward-looking statements, including, but not limited to, statements in this communication with regards to: (i)&#160;statements relating to Aphria&#8217;s and Tilray&#8217;s strategic business combination and the expected terms, timing and closing of the Arrangement including, receipt of required regulatory approvals, shareholder approvals, court approvals and satisfaction of other closing customary conditions; (ii)&#160;estimates of <span style="white-space:nowrap">pro-forma</span> financial information of the combined company, including in respect of expected revenues and production of cannabis; (iii)&#160;estimates of future costs applicable to sales; (iv)&#160;estimates of future capital expenditures; (v)&#160;estimates of future cost reductions, synergies including <span style="white-space:nowrap">pre-tax</span> synergies, savings and efficiencies; (vi)&#160;statements that the combined company anticipates to have scalable medical and <span style="white-space:nowrap">adult-use</span> cannabis platforms expected to strengthen the</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> leadership position in Canada, United States and internationally; (vii)&#160;statements that the combined company is expected to offer a diversified and branded product offering and distribution footprint, world-class cultivation, processing and manufacturing facilities; (viii)&#160;statements in respect of operational efficiencies expected to be generated as a result of the Arrangement in the amount of more than C$100&#160;million of <span style="white-space:nowrap">pre-tax</span> annual cost synergies; (ix)&#160;expectations of future balance sheet strength and future equity; (x)&#160;that the combined company is expected to unlock significant shareholder value; and (xi)&#160;statements under the heading &#8220;Strategic and Financial Benefits&#8221; of this communication. Aphria and Tilray use words such as &#8220;forecast&#8221;, &#8220;future&#8221;, &#8220;should&#8221;, &#8220;could&#8221;, &#8220;enable&#8221;, &#8220;potential&#8221;, &#8220;contemplate&#8221;, &#8220;believe&#8221;, &#8220;anticipate&#8221;, &#8220;estimate&#8221;, &#8220;plan&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;may&#8221;, &#8220;project&#8221;, &#8220;will&#8221;, &#8220;would&#8221; and the negative of these terms or similar expressions to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Various assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements reflect current beliefs of management of Aphria and Tilray with respect to future events and are based on information currently available to each respective management including based on reasonable assumptions, estimates, internal and external analysis and opinions of management of Aphria and Tilray considering their experience, perception of trends, current conditions and expected developments as well as other factors that each respective management believes to be relevant as at the date such statements are made. Forward-looking statements involve significant known and unknown risks and uncertainties. Many factors could cause actual results, performance or achievement to be materially different from any future forward-looking statements. Factors that may cause such differences include, but are not limited to, risks assumptions and expectations described in Aphria&#8217;s and Tilray&#8217;s critical accounting policies and estimates; the adoption and impact of certain accounting pronouncements; Aphria&#8217;s and Tilray&#8217;s future financial and operating performance; the competitive and business strategies of Aphria and Tilray ; the intention to grow the business, operations and potential activities of Aphria and Tilray; the ability of Aphria and Tilray to complete the Arrangement; Aphria&#8217;s and Tilray&#8217;s ability to provide a return on investment; Aphria&#8217;s and Tilray&#8217;s ability to maintain a strong financial position and manage costs, the ability of Aphria and Tilray to maximize the utilization of their existing assets and investments and that the completion of the Arrangement is subject to the satisfaction or waiver of a number of conditions as set forth in the Arrangement Agreement. There can be no assurance as to when these conditions will be satisfied or waived, if at all, or that other events will not intervene to delay or result in the failure to complete the Arrangement. There is a risk that some or all the expected benefits of the Arrangement may fail to materialize or may not occur within the time periods anticipated by Aphria and Tilray. The challenge of coordinating previously independent businesses makes evaluating the business and future financial prospects of the combined company following the Arrangement difficult. Material risks that could cause actual results to differ from forward-looking statements also include the inherent uncertainty associated with the financial and other projections; the prompt and effective integration of the combined company; the ability to achieve the anticipated synergies and value-creation contemplated by the proposed transaction; the risk associated with Aphria&#8217;s and Tilray&#8217;s ability to obtain the approval of the proposed transaction by their shareholders required to consummate the proposed transaction and the timing of the closing of the proposed transaction, including the risk that the conditions to the transaction are not satisfied on a timely basis or at all; the risk that a consent or authorization that may be required for the proposed transaction is not obtained or is obtained subject to conditions that are not anticipated; the outcome of any legal proceedings that may be instituted against the parties and others related to the Arrangement Agreement; unanticipated difficulties or expenditures relating to the transaction, the response of business partners and retention as a result of the announcement and pendency of the transaction; risks relating to the value of Tilray&#8217;s common stock to be issued in connection with the transaction; the impact of competitive responses to the announcement of the transaction; and the diversion of management time on transaction-related issues.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For a more detailed discussion of risks and other factors, see the most recently filed annual information form of Aphria and the annual report filed on form <span style="white-space:nowrap">10-K</span> of Tilray made with applicable securities regulatory authorities and available on SEDAR and EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and neither Aphria nor Tilray undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit<br />Number</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">2.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d64377dex21.htm">Amendment No.&#160;1 to Arrangement Agreement and Plan of Arrangement by and between Tilray and Aphria dated February&#160;19, 2021 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0">
<tr>
<td style="width:45%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">TILRAY, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: February&#160;19, 2021</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">/s/ Brendan Kennedy</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Brendan Kennedy</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">President and Chief Executive Officer</td></tr></table></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d64377dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;19, 2021 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Tilray, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">495 Wellington Street West </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unit 250 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Toronto, ON M5V 1G1 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Brendan Kennedy, Chief Executive Officer </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Dear Mr.&nbsp;Kennedy: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Amendment to the arrangement agreement dated December&nbsp;15, 2020 (the &#147;Arrangement
Agreement&#148;) between Aphria Inc. (&#147;Aphria&#148;) and Tilray, Inc. (&#147;Tilray&#148;) </B></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All capitalized
terms used in this letter agreement (this &#147;<B>Agreement</B>&#148;) but not defined herein shall have the meaning attributed to such terms in the Arrangement Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RECITALS: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">On December&nbsp;15, 2020, Aphria and Tilray entered into the Arrangement Agreement, pursuant to which, and
subject to the conditions set out in the Plan of Arrangement, Aphria and Tilray agreed to implement a court approved arrangement under Section&nbsp;182 of the <I>Business Corporations Act </I>(Ontario) (the &#147;<B>Arrangement</B>&#148;); and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Aphria and Tilray wish to enter into this Agreement to amend certain provisions of the Arrangement Agreement
as contemplated herein. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Now therefore, for good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, Aphria and Tilray hereby confirm, acknowledge and agree as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section&nbsp;2.3(1)(a) of the Arrangement Agreement is hereby deleted in its entirety and replaced with the
following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;(a)&nbsp;&nbsp;&nbsp;&nbsp;convene and conduct the Aphria Meeting in accordance with
the Interim Order, Aphria&#146;s Organizational Documents and applicable Law, as promptly as reasonably practicable after the date hereof (and in any event not later than June&nbsp;30, 2021) and, in this regard, Aphria may abridge, any time periods
that may be abridged under Securities Laws for the purpose of considering the Arrangement Resolution and for any other proper purpose as may be set out in the Aphria Circular and agreed to by Tilray, acting reasonably; set the record date for the
Aphria Shareholders entitled to vote at the Aphria Meeting as promptly as reasonably practicable after the date hereof; and not adjourn, postpone or cancel (or propose the adjournment, postponement or cancellation of) the Aphria Meeting without the
prior written consent of Tilray except as required under Section&nbsp;5.4(5) or as required for quorum purposes (in which case the Aphria Meeting will be adjourned and not cancelled) or reasonably required by Law or by a Governmental Entity (as
determined with external legal counsel);&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section&nbsp;2.5(1)(a) of the Arrangement Agreement is hereby deleted in its entirety and replaced with the
following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;(a)&nbsp;&nbsp;&nbsp;&nbsp;convene and conduct the Tilray Meeting in accordance with
Tilray&#146;s Organizational Documents and applicable Law, as promptly as reasonably practicable after the date hereof (and in any event not later than June&nbsp;30, 2021) and, in this regard, Tilray may abridge, any time periods that may be
abridged under Securities Laws for the purpose of considering the Tilray Resolutions and for any other proper purpose as may be set out in the Tilray Proxy Statement and agreed to by Aphria, acting reasonably; set the record date for the Tilray
Shareholders entitled to vote at the Tilray Meeting as promptly as reasonably practicable after the date hereof; and not adjourn, postpone or cancel (or propose the adjournment, postponement or cancellation of) the Tilray Meeting without the prior
written consent of Aphria except as required under Section&nbsp;5.4(5) or as required for quorum purposes (in which case the Tilray Meeting will be adjourned and not cancelled) or reasonably required by Law or by a Governmental Entity (as determined
with outside legal counsel);&#148; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The reference to &#147;Section&nbsp;7.2(1)(b)(iv) [<I>No Aphria Shareholder Approval</I>]&#148; in
Section&nbsp;7.4(3) of the Arrangement Agreement is hereby deleted and replaced with the following: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;Section&nbsp;7.2(1)(b)(iii) [<I>No Aphria Shareholder Approval</I>]&#148;. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The definition of &#147;Amended Tilray Omnibus Plan&#148; in Section&nbsp;1.1 of the Arrangement Agreement
is hereby deleted in its entirety. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The definition of &#147;Aphria DSUs&#148; in Section&nbsp;1.1 of the Arrangement Agreement is hereby deleted
and replaced with the following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;&#147;<B>Aphria DSUs</B>&#148; means the deferred share units of
Aphria issued pursuant to the Aphria Omnibus Incentive Plan other than the Continuing Aphria DSUs.&#148;. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The definition of &#147;Aphria Options&#148; in Section&nbsp;1.1 of the Arrangement Agreement is hereby
deleted and replaced with the following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;&#147;<B>Aphria Options</B>&#148; means the outstanding
options, if any, to purchase Aphria Shares issued pursuant to the Aphria Benefit Plans, other than the Continuing Aphria Options.&#148;. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The definition of &#147;Aphria RSUs&#148; in Section&nbsp;1.1 of the Arrangement Agreement is hereby deleted
and replaced with the following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;&#147;<B>Aphria RSUs</B>&#148; means the restricted share units
issued to eligible participants under the Aphria Omnibus Incentive Plan other than the Continuing Aphria RSUs.&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The definition of &#147;Aphria Securityholders&#148; in Section&nbsp;1.1 of the Arrangement Agreement is
hereby deleted and replaced with the following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;&#147;<B>Aphria Securityholders</B>&#148; means
the holders of Aphria Shares, Aphria DSUs, Continuing Aphria DSUs, Aphria Options, Continuing Aphria Options, Aphria RSUs, Continuing Aphria RSUs and Aphria Warrants.&#148;. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The following new definitions shall be added to Section&nbsp;1.1 of the Arrangement Agreement following the
definition of &#147;Consideration Shares&#148;: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;&#147;<B>Continuing Aphria DSUs</B>&#148; means
the outstanding deferred share units, if any, issued pursuant to the Aphria Benefit Plans to (i)&nbsp;any directors, officers, senior executives, or other employees, or consultants of Aphria whose appointment, office or employment, or services as
applicable, has ceased on or prior to the Effective Date, (ii)&nbsp;any entity consultants that hold outstanding deferred share units of Aphria on the Effective Date, or (iii)&nbsp;any other holder of an outstanding Aphria DSU not eligible to
receive Replacement DSUs due to applicable provisions of the U.S. Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Continuing Aphria
Options</B>&#148; means the outstanding options, if any, to purchase Aphria Shares issued pursuant to the Aphria Benefit Plans to (i)&nbsp;any directors, officers, senior executives, other employees, or consultants of Aphria whose appointment,
office or employment, or services as applicable, has ceased on or prior to the Effective Date, (ii)&nbsp;any entity consultants that hold outstanding options on the Effective Date, or (iii)&nbsp;any other holder of an outstanding option to acquire
Aphria Shares not eligible to receive Replacement Options due to applicable provisions of the U.S. Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Continuing Aphria RSU</B>&#148; means the outstanding restricted share units, if any, issued pursuant to the Aphria
Benefit Plans to (i)&nbsp;any directors, officers, senior executives. or other employees, or consultants of Aphria whose appointment, office or employment, or services as applicable, has ceased on or prior to the Effective Date, (ii)&nbsp;any entity
consultants that hold outstanding restricted share units of Aphria on the Effective Date, or (iii)&nbsp;any other holder of an outstanding Aphria RSU not eligible to receive Replacement RSUs due to applicable provisions of the U.S. Securities
Act.&#148;. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The definition of &#147;Revised Tilray Organizational Documents&#148; in Section&nbsp;1.1 of the Arrangement
Agreement is hereby deleted and replaced with the following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Revised Tilray Organizational
Documents</B>&#148; means revised Organizational Documents of Tilray, in the form provided to Tilray by Aphria for inclusion in the Tilray Proxy Statement, subject to the approval of Tilray, which approval shall not be unreasonably withheld.&#148;
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The definition of &#147;Stock Exchange Approval&#148; in Section&nbsp;1.1 of the Arrangement Agreement is
hereby deleted and replaced with the following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;&#147;<B>Stock Exchange Approval</B>&#148; means
the conditional approval of Nasdaq to list the Consideration Shares, and any Tilray Shares issuable upon the exercise of any Replacement Options, Continuing Aphria Options, Replacement RSUs, Continuing Aphria RSUs, Replacement DSUs, Continuing
Aphria DSUs, Aphria Warrants, Replacement Warrants and Aphria Convertible Senior Notes, in each case subject only to customary listing conditions.&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The following definition of &#147;Tilray Omnibus Plan&#148; is hereby added to Section&nbsp;1.1 of the
Arrangement Agreement: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;&#147;<B>Tilray Omnibus Plan</B>&#148; means the Amended and Restated 2018
Equity Incentive Plan that was adopted by Tilray on February&nbsp;5, 2018 and amended and restated on May&nbsp;21, 2018.&#148;. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The definition of &#147;Tilray Resolutions&#148; in Section&nbsp;1.1 of the Arrangement Agreement is hereby
deleted and replaced with the following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;&#147;<B>Tilray Resolutions</B>&#148; means (1)&nbsp;a
resolution of the Tilray Shareholders approving the increase of the authorized capital stock of Tilray from 743,333,333 shares to 900,000,000 shares of capital stock, consisting of (i) 890,000,000 shares of common stock (as increased from
733,333,333 shares of common stock under the existing Tilray Organizational Documents) and (ii) 10,000,000 shares of preferred stock (which remains unchanged from the existing Tilray Organizational Documents) (the &#147;<B>Tilray Authorized Share
Resolution</B>&#148;), and (2)&nbsp;a resolution of the Tilray Shareholders approving the issuance of the Consideration Shares, each to be considered at the Tilray Meeting (the &#147;<B>Tilray Share Issuance Resolution</B>&#148;).&#148; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The definition of &#147;Tilray Shares&#148; in Section&nbsp;1.1 of the Arrangement Agreement is hereby
deleted and replaced with the following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;&#147;<B>Tilray Shares</B>&#148; means, prior to the
Effective Time, collectively, the Tilray Class&nbsp;1 Common Stock and the Tilray Class&nbsp;2 Common Stock, and following the Effective Time, the Tilray Class&nbsp;2 Common Stock.&#148; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The definition of &#147;Tilray Shareholder Approval&#148; in Section&nbsp;1.1 of the Arrangement Agreement
is hereby deleted and replaced with the following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;&#147;<B>Tilray Shareholder Approval</B>&#148;
means the approval of (i)&nbsp;the Tilray Authorized Share Resolution by a majority of Tilray Shares outstanding and entitled to vote thereon, and (ii)&nbsp;the Tilray Share Issuance Resolution by the affirmative vote of a majority of votes cast at
the Tilray Meeting on the Tilray Share Issuance Resolution.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section&nbsp;2.9 of the Arrangement Agreement is hereby deleted in its entirety and replaced with the
following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;&#147;Subject to Section&nbsp;2.15, and all other terms and conditions of this
Agreement and the Plan of Arrangement, pursuant to the Arrangement: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(1) all outstanding Aphria Options, whether vested or
unvested, shall cease to represent an option or other right to acquire Aphria Shares and shall be exchanged at the Effective Time for Replacement Options; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(2) each Continuing Aphria Option shall, without any further action on the part of any holder of any Continuing Aphria Option,
be continued on the same terms and conditions as were applicable immediately prior to the Effective Time, except that, pursuant to the terms of the Aphria Omnibus Incentive Plan, the terms of the Continuing Aphria Options shall be amended so as to
substitute for the Aphria Shares subject to such Continuing Aphria Options such number of Tilray Shares equal to (A)&nbsp;the number of Aphria Shares subject to the Continuing Aphria Options immediately prior to the Effective Time, multiplied by
(B)&nbsp;the Exchange Ratio, rounded down to two decimal places; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(3) all outstanding Aphria RSUs, whether vested or
unvested, shall be exchanged at the Effective Time for Replacement RSUs; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(4) each Continuing Aphria RSU shall, without any
further action on the part of any holder of any Continuing Aphria RSU, be continued on the same terms and conditions as were applicable immediately prior to the Effective Time, except that, pursuant to the terms of the Aphria Omnibus Incentive Plan,
the terms of the Continuing Aphria RSUs shall be amended so as to substitute for the Aphria Shares subject to such Continuing Aphria RSUs such number of Tilray Shares equal to (A)&nbsp;the number of Aphria Shares subject to the Continuing Aphria
RSUs immediately prior to the Effective Time, multiplied by (B)&nbsp;the Exchange Ratio, rounded down to two decimal places; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(5) all outstanding Aphria DSUs, whether vested or unvested, shall be exchanged at the Effective Time for Replacement DSUs;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(6) each Continuing Aphria DSU shall, without any further action on the part of any holder of any Continuing Aphria DSU,
be continued on the same terms and conditions as were applicable immediately prior to the Effective Time, except that, pursuant to the terms of the Aphria Omnibus Incentive Plan, the terms of the Continuing Aphria DSUs shall be amended so as to
substitute for the Aphria Shares subject to such Continuing Aphria DSUs such number of Tilray Shares equal to (A)&nbsp;the number of Aphria Shares subject to the Continuing Aphria DSUs immediately prior to the Effective Time, multiplied by
(B)&nbsp;the Exchange Ratio, rounded down to two decimal places; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(7) all outstanding 2016 Aphria Warrants shall be
exchanged at the Effective Time for Replacement Warrants; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(8) all outstanding 2020 Aphria Warrants shall cease to
represent a warrant or other right to acquire Aphria Shares and shall represent rights to receive Tilray Shares in accordance with their terms; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">all in accordance with and subject to the provisions of the Plan of Arrangement.&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section&nbsp;4.2(2)(b)(A) of the Arrangement Agreement is hereby amended as follows: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i)&nbsp;&nbsp;&nbsp;&nbsp;to add &#147;and Continuing Aphria Options&#148; directly after the words &#147;Aphria
Options&#148;; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii)&nbsp;&nbsp;&nbsp;&nbsp;to add &#147;or Continuing Aphria RSUs&#148; directly after the words
&#147;Aphria RSUs&#148;. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section&nbsp;4.2(2)(b)(B) of the Arrangement Agreement is hereby amended as follows: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i)&nbsp;&nbsp;&nbsp;&nbsp;to add &#147;, Continuing Aphria Options&#148; directly after the words &#147;Aphria Options&#148;;
and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii)&nbsp;&nbsp;&nbsp;&nbsp;to add &#147;or Continuing Aphria RSUs&#148; directly after the words &#147;Aphria
RSUs&#148;. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section&nbsp;4.3(3) of the Arrangement Agreement is hereby deleted in its entirety and replaced with the
following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;Tilray shall take such commercially reasonable actions as are necessary to enact the
Revised Tilray Organizational Documents in the manner and as directed by Aphria.&#148; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section&nbsp;4.8(2) of the Arrangement Agreement is hereby deleted in its entirety and replaced with the
following: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;Tilray shall, immediately prior to the Effective Time, take all steps reasonably
necessary to cause the Replacement RSUs, Replacement Options and Replacement DSUs to be issued under the Tilray Omnibus Plan, the Replacement Warrants to be issued, in accordance with the provisions of the Plan of Arrangement.&#148; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section&nbsp;4.8(3)(iii) of the Arrangement Agreement is amended to add &#147;and the Continuing Aphria
Options.&#148; after the words &#147;Replacement Options&#148;. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section&nbsp;6.3(e) of the Arrangement Agreement is hereby deleted in its entirety. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Plan of Arrangement attached as Schedule &#147;A&#148; to the Arrangement Agreement (the &#147;Plan of
Arrangement&#148;) is hereby deleted in its entirety and replaced with the Plan of Arrangement attached as Schedule A to this Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section (2)(a)(iii) of Schedule &#147;C&#148; to the Arrangement Agreement is hereby amended as follows:
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i)&nbsp;&nbsp;&nbsp;&nbsp;to add &#147;and Continuing Aphria Options,&#148; after the words
&#147;Aphria Options&#148;; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii)&nbsp;&nbsp;&nbsp;&nbsp;to add &#147;and Continuing Aphria RSUs&#148; after the words
&#147;Aphria RSUs&#148;; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii)&nbsp;&nbsp;&nbsp;&nbsp;to add &#147;and Continuing Aphria DSUs&#148; after the words
&#147;Aphria DSUs&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section (2)(a) of Schedule &#147;C&#148; to the Arrangement Agreement is hereby amended to add the words
&#147;and Continuing Aphria RSUs&#148; after the words &#147;Aphria RSUs&#148; in the second sentence of Section&nbsp;2(a). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section&nbsp;2(c) of Schedule &#147;C&#148; of the Arrangement Agreement is hereby amended as follows:
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) &nbsp;&nbsp;&nbsp;&nbsp;to add &#147;Continuing Aphria Options,&#148; after the words &#147;Aphria
Options,&#148;; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii)&nbsp;&nbsp;&nbsp;&nbsp;to add &#147;Continuing Aphria RSUs,&#148; after the words &#147;Aphria
RSUs,&#148;; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii)&nbsp;&nbsp;&nbsp;&nbsp;to add &#147;and Continuing Aphria DSUs,&#148; immediately prior to the words
&#147;Aphria DSUs&#148;. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Section&nbsp;4 of Schedule &#147;D&#148; of the Arrangement Agreement is hereby deleted and replaced as
follows: </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:2%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>(4) Vote Required.</B> The Tilray Shareholder Approval is the only
vote of the holders of any class or series of Tilray&#146;s capital stock necessary to adopt this Agreement and otherwise approve and consummate the Arrangement and the other transactions contemplated by this Agreement (other than the approval of
the Revised Tilray Organizational Documents) as set forth herein. The Tilray Shareholder Approval is not subject to MI <FONT STYLE="white-space:nowrap">61-101.&#148;.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General Matters </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">28.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Except for the amendments contemplated in this Agreement, no other amendments to the Arrangement Agreement
will be made by the parties pursuant to this Agreement, and the Arrangement Agreement shall otherwise remain outstanding on identical terms and conditions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">29.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">This Agreement may be executed in counterparts, each of which shall be deemed to be an original but all of
which together shall constitute one and the same instrument. The parties shall be entitled to rely upon delivery of an executed facsimile or similar executed electronic copy of this Agreement, and such facsimile or similar executed electronic copy
shall be legally effective to create a valid and binding agreement between the parties. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">30.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">This Agreement shall be governed, including as to validity, interpretation and effect, by the laws of the
Province of Ontario and the federal laws of Canada applicable therein. Each of the parties hereby irrevocably attorns to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of the Courts of the Province of Ontario situated in the
City of Toronto in respect of all matters arising under and in relation to this Agreement and waives objection to venue of any proceeding in such court or that such court provides an inconvenient forum. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">31.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">This Agreement is binding upon and will enure to the benefit of each party and its respective successors and
permitted assigns. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[</B><B><I>Signature page follows</I></B><B>] </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Very truly yours,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>APHRIA INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Carl Merton</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Carl Merton</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Chief Financial Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Agreed to and accepted as of the date first written above: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>TILRAY, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Brendan Kennedy</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Brendan Kennedy</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Chief Executive Officer</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLAN OF ARRANGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Attached] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE&nbsp;&#147;A&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLAN OF ARRANGEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE PROVISIONS OF SECTION 182 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF THE </B><B><I>BUSINESS CORPORATIONS ACT </I></B><B>(ONTARIO) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTERPRETATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1.1 Definitions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In this Plan of Arrangement, unless there is something in the subject matter or context clearly inconsistent therewith, the following terms
shall have the respective meanings set out below and grammatical variations of those terms shall have corresponding meanings: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>2016 Aphria Warrants</B>&#148; means 200,000 warrants issued by Aphria expiring September&nbsp;26,
2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Aphria</B>&#148; means Aphria Inc. a company incorporated under the laws of the Province of
Ontario; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Aphria Dissenting Shareholder</B>&#148; means a registered holder of Aphria Shares who has duly and
validly exercised the Dissent Rights in respect of the Arrangement Resolution in strict compliance with the Dissent Rights and who has not withdrawn or been deemed to have withdrawn such exercise of Dissent Rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Aphria DSUs</B>&#148; means the deferred share units of Aphria issued pursuant to the Aphria
Omnibus Incentive Plan other than the Continuing Aphria DSUs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Aphria Omnibus Incentive Plan</B>&#148; means the omnibus long-term incentive plan of Aphria
approved at the annual and special meeting of Aphria Shareholders held on November&nbsp;2, 2018; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Aphria Options</B>&#148; means the outstanding options, if any, to purchase Aphria Shares issued
pursuant to the Aphria Benefit Plans, other than the Continuing Aphria Options; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Aphria RSUs</B>&#148; means the restricted share units issued to eligible participants under the
Aphria Omnibus Incentive Plan other than the Continuing Aphria RSUs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Aphria</B> <B>Securityholders</B>&#148; means the holders of Aphria Shares, Aphria DSUs, Continuing
Aphria DSUs, Aphria Options, Continuing Aphria Options, Aphria RSUs, Continuing Aphria RSUs and Aphria Warrants; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Aphria Shares</B>&#148; means the common shares in the capital of Aphria, each entitling the holder
thereof to one (1)&nbsp;vote per share at shareholder meetings of Aphria; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Aphria Warrant Indenture</B>&#148; means the common share purchase warrant indenture dated
January&nbsp;30, 2020 between Aphria and Computershare Trust Company of Canada; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Aphria Warrants</B>&#148; means collectively, the 2016 Aphria Warrants and 7,022,472 warrants
issued by Aphria expiring January&nbsp;30, 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Arrangement</B>&#148; means the arrangement under Section&nbsp;182 of the OBCA on the terms and
subject to the conditions set out in this Plan of Arrangement, subject to any amendments or variations thereto made in accordance with the terms of the Arrangement Agreement or made at the direction of the Court in the Final Order with the consent
of Aphria and Tilray, each acting reasonably; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Arrangement Agreement</B>&#148; means the agreement made as of December&nbsp;15, 2020 between
Aphria and Tilray, including the schedules thereto, together with the Aphria Disclosure Letter and the Tilray Disclosure Letter, as the same may be amended, supplemented, restated or otherwise modified from time to time in accordance with its terms;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Arrangement Resolution</B>&#148; means the special resolution approving the Arrangement passed by
the Aphria Shareholders at the Meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Articles of Arrangement</B>&#148; means the articles of arrangement of Aphria in respect of the
Arrangement, required by the OBCA to be sent to the Director after the Final Order is made, which will be in form and content satisfactory to Aphria and Tilray, each acting reasonably; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(p)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Business</B> <B>Day</B>&#148; means any day of the year, other than a Saturday, Sunday or any day
on which major commercial banking institutions in Toronto, Ontario or New York, New York are required by Law to be closed for business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(q)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Certificate of Arrangement</B>&#148; means the certificate of arrangement giving effect to the
Arrangement, issued by the Director pursuant to the OBCA after the Articles of Arrangement have been filed; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(r)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Code</B>&#148; means the United States Internal Revenue Code of 1986, as amended; <B></B>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(s)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Continuing Aphria DSUs</B>&#148; means the outstanding deferred share units, if any, issued
pursuant to the Aphria Benefit Plans to (i)&nbsp;any directors, officers, senior executives, or other employees, or consultants of Aphria whose appointment, office or employment, or services as applicable, has ceased on or prior to the Effective
Date, (ii)&nbsp;any entity consultants that hold outstanding deferred share units of Aphria on the Effective Date, or (iii)&nbsp;any other holder of an outstanding Aphria DSU not eligible to receive Replacement DSUs due to applicable provisions of
the U.S. Securities Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(t)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Continuing Aphria Options</B>&#148; means the outstanding options, if any, to purchase Aphria
Shares issued pursuant to the Aphria Benefit Plans to (i)&nbsp;any directors, officers, senior executives, other employees, or consultants of Aphria whose appointment, office or employment, or services as applicable, has ceased on or prior to the
Effective Date, (ii)&nbsp;any entity consultants that hold outstanding options on the Effective Date, or (iii)&nbsp;any other holder of an outstanding option to acquire Aphria Shares not eligible to receive Replacement Options due to applicable
provisions of the U.S. Securities Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(u)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Continuing Aphria RSUs</B>&#148; means the outstanding restricted share units, if any, issued
pursuant to the Aphria Benefit Plans to (i)&nbsp;any directors, officers, senior executives. or other employees, or consultants of Aphria whose appointment, office or employment, or services as applicable, has ceased on or prior to the Effective
Date, (ii)&nbsp;any entity consultants that hold outstanding restricted share units of Aphria on the Effective Date, or (iii)&nbsp;any other holder of an outstanding Aphria RSU not eligible to receive Replacement RSUs due to applicable provisions of
the U.S. Securities Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Court</B>&#148; means the Ontario Superior Court of Justice (Commercial List) or any other court
with jurisdiction to consider and issue the Interim Order and the Final Order; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(w)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Depositary</B>&#148; means Odyssey Trust or such other depositary as may be agreed upon by the
Parties acting reasonably; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Director</B>&#148; means the Director appointed under section 278 of the OBCA;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(y)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Dissent</B> <B>Rights</B>&#148; means the rights of dissent of registered Aphria Shareholders in
respect of the Arrangement described in Article 4 of this Plan of Arrangement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(z)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Dissenting Shares</B>&#148; means the Aphria Shares held by Aphria Dissenting Shareholders in
respect of which such Aphria Dissenting Shareholders have given Notice of Dissent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(aa)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Effective Date</B>&#148; means the date shown on the Certificate of Arrangement giving effect to
the Arrangement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(bb)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Effective Time</B>&#148; means 12:01 a.m. (Toronto time) on the Effective Date or such other time
as the Parties agree in writing before the Effective Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(cc)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Exchange Ratio</B>&#148; means 0.8381; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(dd)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Final</B> <B>Order</B>&#148; means the order of the Court in a form acceptable to Aphria and
Tilray, each acting reasonably, approving the Arrangement under section 182(5) of the OBCA, as such order may be affirmed, amended, modified, supplemented or varied by the Court at any time prior to the Effective Date or, if appealed and a stay of
the final order is obtained pending appeal, then, unless such appeal is withdrawn, abandoned or denied, as affirmed or amended on appeal; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ee)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>holder</B>&#148; means, when used with reference to any securities of Aphria, the holder of such
securities shown from time to time in the central securities register maintained by or on behalf of Aphria in respect of such securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ff)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Interim</B> <B>Order</B>&#148; means the interim order of the Court pursuant to Section&nbsp;182(5)
of the OBCA in a form acceptable to Aphria and Tilray, each acting reasonably, providing for, among other things, the calling and holding of the Meeting, as such order may be amended, modified, supplemented or varied by the Court with the consent of
Aphria and Tilray, each acting reasonably, at any time prior to the Final Order or, if appealed and a stay of the final order is obtained pending appeal, then unless such appeal is withdrawn or denied, as affirmed or as amended on appeal;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(gg)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-The-Money</FONT></FONT>
Amount</B>&#148; in respect of an option means the amount, if any, by which the fair market value at that time of the securities subject to the option exceeds the exercise price of the option; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(hh)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Law</B>&#148; means any and all laws, statutes, codes, ordinances, decrees, rules, regulations, <FONT
STYLE="white-space:nowrap">by-laws,</FONT> notices, judicial, arbitral, administrative, ministerial, departmental or regulatory judgments, injunctions, orders, decisions, rulings, determinations or awards, decrees or other requirements of any
Governmental Entity having the force of law and any legal requirements arising under the common law or principles of law or equity and the term &#147;<B>applicable</B>&#148; with respect to such Laws and, in the context that refers to any Person,
means such Laws as are applicable at the relevant time or times to such Person or its business, undertaking, property or securities and emanate from a Governmental Entity having jurisdiction over such Person or its business, undertaking, property or
securities; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Letter of Transmittal</B>&#148; means the letter of transmittal to be delivered by the Shareholders
to the Depositary as described therein; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(jj)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Lien</B>&#148; means any mortgage, deed of trust, charge, pledge, hypothec, security interest,
easement, right of way, zoning restriction, lien (statutory or otherwise), or other third party encumbrance, in each case, whether contingent or absolute; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(kk)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Meeting</B>&#148; means the special meeting of the Aphria Shareholders, including any adjournment
or postponement thereof, called and held in accordance with the Interim Order for the purpose of approving the Arrangement Resolution; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ll)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Notice of Dissent</B>&#148; means a notice of dissent duly and validly given by a registered holder
of Aphria Shares exercising Dissent Rights as contemplated in the Interim Order and as described in Article 4; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(mm)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>OBCA</B>&#148; means the <I>Business Corporations Act </I>(Ontario) and all regulations made
thereunder, as promulgated or amended from time to time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(nn)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Parties</B>&#148; means Aphria and Tilray; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(oo)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Plan of Arrangement</B>&#148; means this plan of arrangement, subject to any amendments or
variations to such plan made in accordance with this Agreement or made at the direction of the Court in the Final Order with the consent of Aphria and Tilray, each acting reasonably; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(pp)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Share Consideration</B>&#148; means, for each Aphria Share, 0.8381 Tilray Shares;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(qq)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Shareholders</B>&#148; means the registered and/or beneficial holders of Aphria Shares, as the
context requires; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(rr)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Tax Act</B>&#148; means the <I>Income Tax Act </I>(Canada) and the regulations thereunder, as may
be amended from time to time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ss)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Tilray</B>&#148; means Tilray, Inc., a corporation incorporated under the laws of the State of
Delaware; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(tt)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Tilray Plan</B>&#148; means the amended and restated 2018 equity incentive plan of Tilray, dated
February&nbsp;5, 2018, as amended and restated on May&nbsp;21, 2018; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(uu)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>Tilray Shares</B>&#148; means, prior to the Effective Time, collectively, the Tilray Class&nbsp;1
Common Stock and the Tilray Class&nbsp;2 Common Stock, and following the Effective Time, the Tilray Class&nbsp;2 Common Stock; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">&#147;<B>U.S. Securities Act</B>&#148; means the <I>United States Securities Act of 1933</I>, as amended,
and the rules and regulations promulgated thereunder. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any capitalized terms used but not defined herein shall have the
meaning ascribed to such terms in the Arrangement Agreement. In addition, words and phrases used herein and defined in the OBCA and not otherwise defined herein or in the Arrangement Agreement shall have the same meaning herein as in the OBCA unless
the context otherwise clearly requires. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1.2 Interpretation Not Affected by Headings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The division of this Plan of Arrangement into Articles, Sections, paragraphs and other portions and the insertion of headings are for
convenience of reference only and shall not affect the construction or interpretation hereof. Unless otherwise indicated, all references to an &#147;Article&#148;, &#147;Section&#148; or &#147;paragraph&#148; followed by a number and/or a letter
refer to the specified Article, Section or paragraph of this Plan of Arrangement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1.3 Number, Gender and Persons </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In this Plan of Arrangement, unless the context otherwise clearly requires, words used herein importing the singular include the plural and
vice versa; words imparting any gender shall include all genders and the neuter gender; and words imparting persons shall include individuals, partnerships, limited liability companies, associations, corporations, funds, unincorporated
organizations, governments, regulatory authorities and other entities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1.4 Date of Any Action </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any date on which any action is required to be taken hereunder by any of the Parties is not a Business Day, then such action shall be
required to be taken on the next succeeding day which is a Business Day. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1.5 Time </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Time shall be of the essence in every matter or action contemplated hereunder. All times expressed herein or in the Letter of Transmittal and
Election Form refer to the local time of Aphria (being the time in Toronto, Ontario) unless otherwise stipulated herein or therein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1.6 Statutory References </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless otherwise indicated, references in this Plan of Arrangement to any statute include all regulations made pursuant to such statute and the
provisions of any statute or regulation which amends, supplements or supersedes any such statute or regulation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1.7
Currency </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless otherwise stated, all references in this Plan of Arrangement to sums of money are expressed in lawful money of Canada,
and &#147;$&#148; refers to Canadian dollars. All references in this Plan of Arrangement to sums of money expressed in lawful money of the United States refers to &#147;US$&#148;. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;2 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EFFECT
OF THE ARRANGEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.1 Arrangement Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Plan of Arrangement is made pursuant to, is subject to the provisions of, and forms a part of the Arrangement Agreement, except in respect
of the sequence of the steps comprising the Arrangement, which shall occur in the order set forth herein. This Plan of Arrangement constitutes an arrangement as referred to in Section&nbsp;182 of the OBCA. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.2 Binding Effect </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Plan of Arrangement will become effective commencing at the Effective Time and shall be binding upon Tilray, Aphria, Aphria
Securityholders, the Depositary, the transfer agents in respect of the Aphria Shares and the Tilray Shares and all other Persons without any further act or formality required on the part of any Person. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.3 Transfers Free and Clear </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any transfer of securities pursuant to this Plan of Arrangement shall be free and clear of all Liens, claims and encumbrances. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;3 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARRANGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.1 The Arrangement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Commencing at the Effective Time, each of the events set out below shall occur and be deemed to occur in the following sequence, in each case
without any further authorization, act or formality on the part of any Person: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">at the Effective Time: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">each Dissenting Share held by an Aphria Dissenting Shareholder who is ultimately determined to be entitled
to be paid the fair value of the Dissenting Shares in respect of which such Aphria Dissenting Shareholder has exercised Dissent Rights shall be, and shall be deemed to be, transferred by the holder thereof, without any further act or formality on
its part, to Aphria (free and clear of all Liens) and such Aphria Dissenting Shareholder will cease to be the holder thereof or to have any rights as a holder in respect of such Dissenting Share other than the right to be paid the fair value of such
Dissenting Share determined and payable in accordance with Article 4; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">at the same time as the step in Section&nbsp;3.1(b)(i) occurs, the name of each Aphria Dissenting
Shareholder shall be removed from the register of the Aphria Shares and such Dissenting Shares shall be automatically cancelled as of the Effective Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">at the same time as the steps in Section&nbsp;3.1(a) occur: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">each Aphria Share outstanding immediately prior to the Effective Time (other than Dissenting Shares held by
Aphria Dissenting Shareholders who are ultimately determined to be entitled to be paid the fair value of their Dissenting Shares as determined in accordance with Article 4), shall be, and shall be deemed to be, transferred by the holder thereof to
Tilray (free and clear of all Liens) in exchange for issuance of the Share Consideration; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">at the same time as the step in Section&nbsp;3.1(b)(i) occurs, the holder of each Aphria Share transferred
to Tilray pursuant to Section&nbsp;3.1(b)(i) shall cease to be the holder thereof, or to have any rights as a holder thereof other than the right to receive the Share Consideration issuable in respect of each Aphria Share held pursuant to
Section&nbsp;3.1(b)(i) and shall be removed from the register of the Aphria Shares and legal and beneficial title to each such Aphria Share shall be transferred to Tilray and Tilray will be and be deemed to be the transferee and legal and beneficial
owner of such Aphria Share (free and clear of any Liens) and will be entered in the central securities register of Aphria as the sole holder thereof; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Tilray will be the holder of all of the outstanding Aphria Shares; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">immediately after the steps in Section&nbsp;3.1(b) occur: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">each Aphria Option, other than any Continuing Aphria Option, to the extent it has not been exercised as of
the Effective Date, will be exchanged by the holder thereof, without any further act or formality and free and clear of all Liens, for a stock option (a &#147;<B>Replacement Option</B>&#148;) to purchase a number of Tilray Shares equal to the
product of the Exchange Ratio, rounded down to two decimal places, multiplied by the number of Aphria Shares issuable on exercise of such Aphria Option immediately prior to the Effective Time (rounded down to the next whole number of Tilray Shares)
for an exercise price per Tilray Share (rounded up to the nearest whole cent) equal to the exercise price per share of such Aphria Option immediately prior to the Effective Time divided by the Exchange Ratio, rounded down to two decimal places, and
the Aphria Options shall thereupon be cancelled. The term to expiry, conditions to and manner of exercise and other terms and conditions of each of the Replacement Options shall be the same as the terms and conditions of the Aphria Option for which
it is exchanged except that such Replacement Options shall be governed by the terms and conditions of the Tilray Plan and, in the event of any inconsistency or conflict the Tilray Plan shall govern. It is intended that subsection 7(1.4) of the Tax
Act apply to the exchange of Aphria Options by Aphria Securityholders resident in Canada who acquired Aphria Options by virtue of their employment. Accordingly, and notwithstanding the foregoing, if required, the exercise price of a Replacement
Option held by such an Aphria Securityholder will be increased such that the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-The-Money</FONT></FONT> Amount of the Replacement Option immediately after the exchange does not exceed
the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-The-Money</FONT></FONT> Amount of the Aphria Option immediately before the exchange. For any Aphria Option that is intended to qualify as an &#147;incentive stock option&#148;
within the meaning of Section&nbsp;422 of the Code, it is intended that such exchange will comply with Treasury Regulation Section&nbsp;1.424(1)(a). For any Aphria Option that is a nonqualified option held by a US taxpayer, it is intended that such
exchange will be implemented in a manner intended comply with Section&nbsp;409A of the Code. Any document previously evidencing the Aphria Option shall thereafter evidence and be deemed to evidence such Replacement Option and no certificates
evidencing the Replacement Options shall be issued; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">each Continuing Aphria Option shall, without any further action on the part of any holder of any Continuing
Aphria Option, be continued on the same terms and conditions as were applicable immediately prior to the Effective Time, except that, pursuant to the terms of the Aphria Omnibus Incentive Plan, the terms of the Continuing Aphria Options shall be
amended so as to substitute for the Aphria Shares subject to such Continuing Aphria Options such number of Tilray Shares equal to (A)&nbsp;the number of Aphria Shares subject to the Continuing Aphria Options immediately prior to the Effective Time,
multiplied by (B)&nbsp;the Exchange Ratio, rounded down to two decimal places; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">each Aphria RSU other than a Continuing Aphria RSU, to the extent it has not been exercised as of the
Effective Date, will be exchanged by the holder thereof, without any further act or formality and free and clear of all Liens, for an award of restricted share units granted by Tilray (the &#147;<B>Replacement RSUs</B>&#148;) in respect of a number
of Tilray Shares equal to the product of the Exchange Ratio, rounded down to two decimal places, multiplied by the number of Aphria Shares underlying such Aphria RSUs immediately prior to the Effective Time (rounded down to the next whole number of
Tilray Shares), and the Aphria RSUs shall thereupon be cancelled. The term to expiry, conditions to and manner of receipt and other terms and conditions of each of the Replacement RSUs shall be the same as the terms and conditions of the Aphria RSU
for which it is exchanged </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
except that such Replacement RSU shall be governed by the terms and conditions of the Tilray Plan and, in the event of any inconsistency or conflict the Tilray Plan shall govern. Any document
previously evidencing the Aphria RSUs shall thereafter evidence and be deemed to evidence such Replacement RSUs and no certificates evidencing the Replacement RSUs shall be issued. It is intended that subsection 7(1.4) of the Tax Act apply to the
exchange of Aphria RSUs by Aphria Securityholders resident in Canada who acquired Aphria RSUs by virtue of their employment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">each Continuing Aphria RSU shall, without any further action on the part of any holder of any Continuing
Aphria RSU, be continued on the same terms and conditions as were applicable immediately prior to the Effective Time, except that, pursuant to the terms of the Aphria Omnibus Incentive Plan, the terms of the Continuing Aphria RSUs shall be amended
so as to substitute for the Aphria Shares subject to such Continuing Aphria RSUs such number of Tilray Shares equal to (A)&nbsp;the number of Aphria Shares subject to the Continuing Aphria RSUs immediately prior to the Effective Time, multiplied by
(B)&nbsp;the Exchange Ratio, rounded down to two decimal places; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">each Aphria DSU other than a Continuing Aphria DSU, to the extent it has not been exercised as of the
Effective Date, will be exchanged by the holder thereof, without any further act or formality and free and clear of all Liens, for an award of deferred share units granted by Tilray (the &#147;<B>Replacement DSUs</B>&#148;) in respect of a number of
Tilray Shares equal to the product of the Exchange Ratio, rounded down to two decimal places, multiplied by the number of Aphria Shares underlying such Aphria DSUs immediately prior to the Effective Time (rounded down to the next whole number of
Tilray Shares), and the Aphria DSUs shall thereupon be cancelled. The term to expiry, conditions to and manner of receipt and other terms and conditions of each of the Replacement DSUs shall be the same as the terms and conditions of the Aphria DSU
for which it is exchanged except that such Replacement DSU shall be governed by the terms and conditions of the Tilray Plan and, in the event of any inconsistency or conflict the Tilray Plan shall govern. Any document previously evidencing the
Aphria DSUs shall thereafter evidence and be deemed to evidence such Replacement DSUs and no certificates evidencing the Replacement DSUs shall be issued. It is intended that subsection 7(1.4) of the Tax Act apply to the exchange of Aphria DSUs by
Aphria Securityholders resident in Canada who acquired Aphria DSUs by virtue of their employment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">each Continuing Aphria DSU shall, without any further action on the part of any holder of any Continuing
Aphria DSU, be continued on the same terms and conditions as were applicable immediately prior to the Effective Time, except that, pursuant to the terms of the Aphria Omnibus Incentive Plan, the terms of the Continuing Aphria DSUs shall be amended
so as to substitute for the Aphria Shares subject to such Continuing Aphria DSUs such number of Tilray Shares equal to (A)&nbsp;the number of Aphria Shares subject to the Continuing Aphria DSUs immediately prior to the Effective Time, multiplied by
(B)&nbsp;the Exchange Ratio, rounded down to two decimal places; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">each 2016 Aphria Warrant, to the extent it has not been exercised as of the Effective Date, will be
exchanged by the holder thereof, without any further act or formality and free and clear of all Liens, for a warrant (a &#147;<B>Replacement</B> <B>Warrant</B>&#148;) to purchase a number of Tilray Shares equal to the product of the Exchange Ratio,
rounded down to two decimal places, multiplied by the number of Aphria Shares issuable on exercise of such Aphria Warrant immediately prior to the Effective Time for an exercise price per Tilray Share equal to the exercise price per share of such
Aphria Warrant immediately prior to the </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Effective Time divided by the Exchange Ratio, rounded down to two decimal places, and rounded up to the nearest whole cent (provided that, if the foregoing calculation results in a Replacement
Warrant being exercisable for a fraction of a Tilray Share, then the number of Tilray Shares subject to such Replacement Warrant shall be rounded down to the next whole number of Tilray Shares) and the 2016 Aphria Warrants shall thereupon be
cancelled. The term to expiry, conditions to and manner of exercise and other terms and conditions of each of the Replacement Warrants shall be the same as the terms and conditions of the 2016 Aphria Warrant for which it is exchanged. Any document
previously evidencing a 2016 Aphria Warrant shall thereafter evidence and be deemed to evidence such Replacement Warrant and no certificates evidencing the Replacement Warrants shall be issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">other than the 2016 Aphria Warrants, each Aphria Warrant shall, without any further action on the part of
any holder of Aphria Warrant, be continued on the same terms and conditions as were applicable immediately prior to the Effective Time, except that, pursuant to the terms of the Aphria Warrant Indenture, the terms of the Aphria Warrants shall be
amended so as to substitute for the Aphria Shares subject to such Aphria Warrants such number of Tilray Shares equal to (A)&nbsp;the number of Aphria Shares subject to the Aphria Warrants immediately prior to the Effective Time, multiplied by
(B)&nbsp;the Exchange Ratio, rounded down to two decimal places; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the Aphria Warrant Indenture shall be terminated and, for greater certainty, all rights to receive any
securities of the Aphria formerly held by Aphria Securityholders shall be extinguished; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">no person shall have any rights, liabilities or other obligations in respect of the share capital of Aphria
other than Tilray and each holder of Aphria Shares, Aphria Options, Continuing Aphria Options, Aphria RSUs, Continuing Aphria RSUs, Aphria DSUs, Continuing Aphria DSUs or 2016 Aphria Warrants outstanding immediately prior to the Effective Time, with
respect to each step set out above applicable to such holder, shall be deemed, at the time such step occurs, to have executed and delivered all consents, releases, assignments and waivers, statutory or otherwise, required to transfer all Aphria
Shares, Aphria Options, Aphria RSUs, Aphria DSUs or 2016 Aphria Warrants held by such holder in accordance with such step. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;4 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DISSENT
RIGHTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;4.1 Rights of Dissent </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Pursuant to the Interim Order, each registered Shareholder may exercise rights of dissent
(&#147;<B>Dissent</B> <B>Rights</B>&#148;) pursuant to and in the manner set forth in Section&nbsp;185 of the OBCA, as modified by this Article 4 and the Interim Order; provided, however, that written objection to the Arrangement Resolution, in the
manner contemplated by Subsection 185(6) of the OBCA, must be sent to and received by Aphria by no later than 4:00 p.m. (Toronto time) on the second Business Day immediately prior to the Meeting. Shareholders who duly exercise such rights of dissent
and who: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">are ultimately determined to be entitled to be paid by Aphria, the fair value for Aphria Shares in respect
of which they have exercised Dissent Rights will be deemed to have irrevocably transferred such Aphria Shares to Aphria pursuant to Section&nbsp;3.1(b)(i) in consideration of such fair value and will not be entitled to any other payment or
consideration, including any payment that would be payable under the Arrangement had such holders not exercised their Dissent Rights in respect of such Aphria Shares; or </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">are ultimately not entitled, for any reason, to be paid by Aphria, the fair value for Aphria Shares in
respect of which they have exercised Dissent Rights will be deemed to have participated in the Arrangement on the same basis as a Shareholder who has not exercised Dissent Rights, as at and from the time specified in Section&nbsp;3.1(b)(i) and be
entitled to receive only the consideration set forth in Section&nbsp;3.1(b)(i) that such holder would have received if such holder had not exercised Dissent Rights; </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">but in no case will Aphria or Tilray or any other person be required to recognize such holders as holders of Aphria Shares
after the completion of the steps set forth in Section&nbsp;3.1(b), and each Aphria Dissenting Shareholder will cease to be entitled to the rights of a Shareholder in respect of Aphria Shares in relation to which such Aphria Dissenting Shareholder
has exercised Dissent Rights and the central securities register of Aphria will be amended to reflect that such former holder is no longer the holder of such Aphria Shares as and from the Effective Time and that such Aphria Shares have been
cancelled. For greater certainty, and in addition to any other restriction under Section&nbsp;185 of the OBCA, a Shareholder who has voted, or instructed a proxyholder to vote, in favour of the Arrangement Resolution shall not be entitled to
exercise Dissent Rights with respect to the Arrangement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">For greater certainty in accordance with the OBCA, none of the following are entitled to exercise Dissent
Rights: (i)&nbsp;holders of Aphria Options; (ii)&nbsp;holders of Continuing Aphria Options, (iii)&nbsp;holders of Aphria RSUs, (iv)&nbsp;holders of Continuing Aphria RSUs, (v)&nbsp;holders of Aphria DSUs, (vi)&nbsp;holder of Continuing Aphria DSUs,
(vii)&nbsp;holders of 2016 Aphria Warrants, and (viii)&nbsp;holders of Aphria Shares who vote in favour of the Arrangement Resolution. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;5 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELIVERY
OF TILRAY SHARES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.1 Delivery of Tilray Shares </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Upon return to the Depositary of a properly completed Letter of Transmittal by a registered former Aphria
Shareholder together with certificate(s) or a direct registration statement (DRS) Advice representing one or more Aphria Shares that such Aphria Shareholder held immediately before the Effective Time and such additional documents and instruments as
the Depositary may reasonably require, the Aphria Shareholder shall be entitled to receive the Share Consideration in accordance with Section&nbsp;3.1(b) hereof and the holder of such surrendered certificate or DRS Advice shall be entitled to
receive in exchange therefor, and the Depositary shall deliver to such holder following the Effective Time, certificate(s) or DRS Advice recorded on a book-entry basis representing the Tilray Shares that such holder is entitled to receive in
accordance with Section&nbsp;3.1(b) hereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">After the Effective Time and until surrendered for cancellation as contemplated by Section&nbsp;5.1(a)
hereof, each certificate or DRS Advice, if any, that immediately prior to the Effective Time represented one or more Aphria Shares shall be deemed at all times to represent only the right to receive in exchange therefor the Share Consideration that
the holder of such certificate, if any, is entitled to receive in accordance with Section&nbsp;3.1<FONT STYLE="font-size:1pt">&nbsp;</FONT>(b)&nbsp;hereof. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">For greater certainty, none of the holders of Aphria Options, holders of Continuing Aphria Options, holders
of Aphria RSUs, holders of Continuing Aphria RSUs, holders of Aphria DSUs, holders of Continuing Aphria DSUs, holders of 2016 Aphria Warrants or Aphria Shareholders shall be entitled to receive any consideration with respect to such Aphria
securities other than consideration such holder is entitled to receive in accordance with Section&nbsp;3.1 and, for greater certainty, no such former holder will be entitled to receive any interest, dividends, premium or other payment in connection
therewith. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.2 Dividends and Distributions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No dividends or other distributions declared or made after the Effective Time with respect to Tilray Shares with a record date after the
Effective Time shall be paid to the holder of any unsurrendered certificate which immediately prior to the Effective Time represented outstanding Aphria Shares that were exchanged pursuant to Section&nbsp;3.1(b) unless and until the holder of record
of such certificate shall surrender such certificate (or affidavit in accordance with Section&nbsp;5.5) in accordance with Section&nbsp;5.1(a). Subject to applicable law, at the time of such surrender of any such certificate (or in the case of
clause (B)&nbsp;below, at the appropriate payment date), there shall be paid to the holder of record of the certificates formerly representing whole Aphria Shares, without interest, (A)&nbsp;the amount of dividends or other distributions with a
record date after the Effective Time theretofore paid with respect to each whole Tilray Share issued to such holder, and (B)&nbsp;on the appropriate payment date, the amount of dividends or other distributions with a record date after the Effective
Time but prior to surrender and a payment date subsequent to surrender payable with respect to such whole Tilray Share. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.3 Fractional Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In no event shall any holder of Aphria Shares be entitled to a fractional Tilray Share. Where the aggregate number of Tilray Shares to be
issued to a holder of Aphria Shares as consideration under this Arrangement would result in a fraction of an Aphria Share being issuable, the number of Tilray Shares to be received by such holder shall be rounded down to the nearest whole Tilray
Share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.4 Adjustment to Share Consideration </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">THE NUMBER OF SHARE CONSIDERATION, IF ANY, THAT AN APHRIA SHAREHOLDER IS ENTITLED TO RECEIVE PURSUANT TO SECTION&nbsp;3.1(B) SHALL BE ADJUSTED
TO REFLECT FULLY THE EFFECT OF ANY STOCK SPLIT, REVERSE SPLIT OR STOCK DIVIDEND (INCLUDING ANY DIVIDEND OR DISTRIBUTION OF SECURITIES CONVERTIBLE INTO COMMON SHARES), CONSOLIDATION, REORGANIZATION, RECAPITALIZATION OR OTHER LIKE CHANGE WITH RESPECT
TO COMMON SHARES OCCURRING AFTER THE DATE OF THE ARRANGEMENT AGREEMENT AND PRIOR TO THE EFFECTIVE TIME. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.5 Effective
Time Procedures </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Following the receipt of the Final Order and prior to the Effective Date, Tilray shall deliver or arrange to be
delivered to the Depositary the Tilray Shares required to be issued to the Aphria Shareholders in accordance with the provisions of Section&nbsp;3.1, which Tilray Shares shall be held by the Depositary as agent and nominee for such Aphria
Shareholders for delivery to such Aphria Shareholders in accordance with the provisions of Article 5. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.6 Loss of
Certificates </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event any certificate which immediately prior to the Effective Time represented any outstanding Aphria Shares that
were acquired by the Tilray pursuant to Section&nbsp;3.1(b) has been lost, stolen or destroyed, upon the making of an affidavit of that fact by the former holder of such Aphria Shares, the Depositary will, in exchange for such lost, stolen or
destroyed certificate, deliver to such former holder of Aphria Shares, or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
make available for pick up at its offices, the Tilray Shares such former holder is entitled to receive in respect of such Aphria Shares pursuant to Section&nbsp;3.1(b) together with any
distributions or dividends which such holder is entitled to receive pursuant to Section&nbsp;5.2 and less, in each case, any amounts withheld pursuant to Section&nbsp;5.7. When authorizing such delivery in relation to any lost, stolen or destroyed
certificate, the former holder of such Aphria Shares will, as a condition precedent to the delivery of Tilray Shares, give a bond satisfactory to Tilray and the Depositary (acting reasonably) in such sum as Tilray may direct or otherwise indemnify
Aphria, Tilray and the Depositary against any claim that may be made against any of them with respect to the certificate alleged to have been lost, stolen or destroyed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.7 Extinction of Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any certificate or book-entry advice statements which immediately prior to the Effective Time represented one or more outstanding Aphria Shares
that were acquired by Tilray pursuant to Section&nbsp;3.1(b) which is not deposited with the Depositary in accordance with the provisions of Section&nbsp;5.1(a) on or before the sixth (6<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>)
anniversary of the Effective Date shall, on the sixth (6<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) anniversary of the Effective Date, cease to represent a claim or interest of any kind or nature whatsoever, whether as a securityholder
or otherwise and whether against Aphria, Tilray, the Depositary or any other person. On such date, the Share Consideration such former holder of Tilray Shares would otherwise have been entitled to receive, together with any distributions or
dividends such holder would otherwise have been entitled to receive pursuant to Section&nbsp;5.2, shall be deemed to have been surrendered for no consideration to Tilray. Neither Aphria nor Tilray will be liable to any person in respect of any cash
or securities (including any cash or securities previously held by the Depositary in trust for any such former holder) which is forfeited to Tilray or delivered to any public official pursuant to any applicable abandoned property, escheat or similar
law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.8 Withholding Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Tilray, Aphria or the Depositary, as applicable, shall be entitled to deduct or withhold, from any amounts payable or otherwise deliverable to
any person pursuant to the Arrangement or this Agreement (including, without limitation, any payments to Dissenting Aphria Shareholders) such amounts as Tilray, Aphria or the Depositary, as applicable, determines, acting reasonably, are required to
be deducted or withheld with respect to such payment or delivery under the Tax Act, the U.S. Tax Code or any provision of any other applicable Laws. To the extent that such amounts are so deducted or withheld, such amounts shall be treated for all
purposes under this Agreement as having been paid to the person to whom such amounts would otherwise have been paid, provided that such deducted or withheld amounts are actually remitted to the appropriate tax authority. Each of Tilray, Aphria or
the Depositary, as applicable, is hereby authorized to sell or otherwise dispose of, on behalf of such person, such portion of any share or other security deliverable to such person as is necessary to provide sufficient funds to Tilray, Aphria or
the Depositary, as the case may be, to enable it to comply with such deduction or withholding requirement and Tilray, Aphria or the Depositary shall notify such person thereof and remit the applicable portion of the net proceeds of such sale to the
appropriate taxing authority and, if applicable, any portion of such net proceeds that is not required to be so remitted shall be paid to such person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.9 U.S. Securities Laws Exemption </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding any provision herein to the contrary, the parties each agree that the Plan of Arrangement will be carried out with the
intention that all Tilray Shares, Replacement Options, Replacement RSUs, Replacement DSUs and Replacement Warrants to be issued by Tilray to Shareholders, holders of Aphria Options, holders of Aphria RSUs, holders of Aphria DSUs and holders of 2016
Aphria Warrants, respectively, in exchange for their Aphria Shares, Aphria Options, Aphria RSUs, Aphria DSUs and 2016 Aphria Warrants, respectively, pursuant to the Plan of Arrangement will be issued and exchanged in reliance on the exemption from
the registration requirements of the U.S. Securities Act as provided by Section&nbsp;3(a)(10) thereof and applicable state securities laws, and pursuant to the terms, conditions and procedures set forth in the Arrangement Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;6 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6.1 Amendments to Plan of Arrangement </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Aphria and Tilray reserve the right to amend, modify or supplement this Plan of Arrangement at any time and
from time to time prior to the Effective Time, provided that each such amendment, modification or supplement must be (i)&nbsp;set out in writing, (ii)&nbsp;approved by Aphria and Tilray, (iii)&nbsp;filed with the Court and, if made following the
Meeting, approved by the Court, and (iv)&nbsp;communicated to or approved by the Shareholders if and as required by the Court. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Any amendment, modification or supplement to this Plan of Arrangement pursuant to Section&nbsp;6.1(a) may be
proposed by Aphria at any time prior to the Meeting (provided Tilray shall have consented thereto, such consent not to be unreasonably withheld or delayed) with or without any other prior notice or communication and, if so proposed and accepted by
the persons voting at the Meeting (other than as may be required under the Interim Order), will become part of this Plan of Arrangement for all purposes. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Any amendment, modification or supplement to this Plan of Arrangement that is approved or directed by the
Court following the Meeting will be effective only if such amendment, modification or supplement (i)&nbsp;is consented to by each of Aphria and Tilray and (ii)&nbsp;if required by the Court or applicable law, is consented to by Shareholders voting
in the manner directed by the Court. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Any amendment, modification or supplement to this Plan of Arrangement may be made following the Effective
Date but shall only be effective if it is consented to by each of Aphria and Tilray provided that such amendment, modification or supplement concerns a matter which, in the reasonable opinion of Aphria and Tilray, is of an administrative nature
required to better give effect to the implementation of this Plan of Arrangement and is not adverse to the financial or economic interests of Aphria and Tilray or any former Aphria Securityholder. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;7 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Plan of
Arrangement may be withdrawn prior to the Effective Time in accordance with the terms of the Arrangement Agreement. Upon the termination of this Plan of Arrangement pursuant to Section&nbsp;7.2 of the Arrangement Agreement, no Party shall have any
liability or further obligation to any other Party hereunder other than as set out in the Arrangement Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;8
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FURTHER ASSURANCES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8.1 Further Assurances </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding that the transactions and events set out herein will occur and be deemed to occur in the order set out in this Plan of
Arrangement without any further act or formality, each of the Parties to the Arrangement Agreement will make, do and execute, or cause to be made, done and executed, any such further acts, deeds, agreements, transfers, assurances, instruments or
documents as may reasonably be required by any of them in order to further document or evidence any of the transactions or events set out herein. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8.2 Paramountcy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">From and after the Effective Time: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">this Plan of Arrangement shall take precedence and priority over any and all rights related to the
securities of Aphria issued prior to the Effective Time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the rights and obligations of the holders of the securities of Aphria and any trustee and transfer agent
therefor, shall be solely as provided for in this Plan of Arrangement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">all actions, causes of actions, claims or proceedings (actual or contingent, and whether or not previously
asserted) based on or in any way relating to securities of Aphria shall be deemed to have been settled, compromised, released and determined without liability except as set forth herein. </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>tlry-20210219.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 67.2 -->
<!-- Creation date: 2/19/2021 10:19:26 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:tlry="http://www.tilray.com/20210219"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:us-types="http://fasb.org/us-types/2020-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.tilray.com/20210219"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tlry-20210219_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tlry-20210219_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>tlry-20210219_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 67.2 -->
<!-- Creation date: 2/19/2021 10:19:26 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>tlry-20210219_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 67.2 -->
<!-- Creation date: 2/19/2021 10:19:26 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="tlry-20210219.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="26.331" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="31.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>d64377d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tlry-20210219.xsd" xlink:type="simple"/>
    <context id="duration_2021-02-19_to_2021-02-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001731348</identifier>
        </entity>
        <period>
            <startDate>2021-02-19</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="duration_2021-02-19_to_2021-02-19"
      id="Hidden_dei_AmendmentFlag_duration_2021-02-19_to_2021-02-19">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-02-19_to_2021-02-19"
      id="Hidden_dei_EntityCentralIndexKey_duration_2021-02-19_to_2021-02-19">0001731348</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2021-02-19_to_2021-02-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-02-19_to_2021-02-19">2021-02-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2021-02-19_to_2021-02-19">Tilray, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-02-19_to_2021-02-19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2021-02-19_to_2021-02-19">001-38594</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-02-19_to_2021-02-19">82-4310622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-02-19_to_2021-02-19">1100 Maughan Rd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-02-19_to_2021-02-19">Nanaimo</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2021-02-19_to_2021-02-19">BC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="duration_2021-02-19_to_2021-02-19">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-02-19_to_2021-02-19">V9X 1J2</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2021-02-19_to_2021-02-19">844</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-02-19_to_2021-02-19">845-7291</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-02-19_to_2021-02-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-02-19_to_2021-02-19">true</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-02-19_to_2021-02-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-02-19_to_2021-02-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-02-19_to_2021-02-19">Class&#160;2 Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-02-19_to_2021-02-19">TLRY</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-02-19_to_2021-02-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-02-19_to_2021-02-19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139754839374408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 19, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 19,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Tilray, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-4310622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1100 Maughan Rd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nanaimo<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">BC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">V9X 1J2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">845-7291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class&#160;2 Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TLRY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001731348<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M^KZ^AH8/$L];,J=[_!EJ,:@W6]5C6)>E:H\_A?<HN9\;[O\2Q0]02P,$%
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M>FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ
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M4')O<',O8V]R92YX;6Q02P$"% ,4    "  @K5-2F5R<(Q &  "<)P  $P
M            @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M ""M4U(E4'Z-300  -T0   8              " @0X(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    "  @K5-2@ZFE ]0!   R!@  #0
M            @ &1#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ""M4U*7
MBKL<P    !,"   +              "  9 .  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( ""M4U(<.&7J/P$  #P"   /              "  7D/  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    "  @K5-2)!Z;HJT   #X 0  &@
M        @ 'E$   >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    "  @K5-299!YDAD!  #/ P  $P              @ '*$0  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   4$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d64377d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d64377d8k.htm">d64377d8k.htm</File>
    <File>d64377dex21.htm</File>
    <File>tlry-20210219.xsd</File>
    <File>tlry-20210219_lab.xml</File>
    <File>tlry-20210219_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d64377d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d64377d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tlry-20210219_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tlry-20210219_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "tlry-20210219.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "tlry",
   "nsuri": "http://www.tilray.com/20210219",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d64377d8k.htm",
      "contextRef": "duration_2021-02-19_to_2021-02-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d64377d8k.htm",
      "contextRef": "duration_2021-02-19_to_2021-02-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.tilray.com//20210219/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001193125-21-049397-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-049397-xbrl.zip
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MO94$4@492!9CLOOZV?:#">Y1HN!=']@9H_C!6(2FBN2$%  0-JGJ"1(6K\S
MAZ 1%\)*TRH1T99##Y".NLT*M$>S?#6U !J3"080MSBQ*]S2B^R&6ACJM)(N
M)>H!16D"!B3/TG%B'K>!(FY!OR?**&[;839O&OB0D[)7-U8<PS=D(21Q;D2'
M8;=5NT4C5G=F1^9G"2@^[%B1[ V=3:VD):%,ZBZT-\)H\'I0<B.N;@5B_&XL
MXDH;$!8@*P!%MUQ&A"$3$$(EX*:\35(CAP)2N0:O=F1/(<]O (S-;22QL Y)
MJ7PR3=%+KF@#[=1>$VN F^U9!]F>95K%NS,50+Y'9E\],\/;>K+T+'%4$0XR
M\4[ ,!SQC)H8U)%$)"?&W+DZ>W5R28.=O7H#GP &)/_<J"E&LV%=)-"MAY57
MTK_/KK@N,O<2E@QI;SD;@>;,U83=3A^W)<146-U4Q^N2 )HC$<_-6RPM"[XI
MQ <9^P[NDEXJZ4%R%FL!1]I'", @!W:'A:1V(T]S3^%.#,F"V_'NU:3DRPB<
M&0<ZQN1QA0&Q5A%GH1'<#K!+E*!DY<(\._WNWBY;><_#TX-^ZZ#_9*]I0U X
M%1HI$8YQR:=C+J+V&Y5H_3<9X-DSO "ZB?!!0V-QP.)70X213J1CM";<DF$&
MO%-4#SH=J?S[I:7MWU+%BM K K%,8L;R UZ0RN@JX- YV:]= D&WK9O]Z-;"
M!Y0W>$0/Y:5U5&Q5,:UERR;"?$S#=R@-ATGERXH0=$V '-RT%B<^3.A,H>5J
M8:X(@(DF2(S0!6W=T%J/TYH%:V_!G@Q !K'^H-,(!<_/,66[9&Z! N8J=,[2
M%&!#NK@;)PA4T\:C@+.8 JL$UE* N0Z #K*<F,O^TV:&1.XUHET.3>V<"U0'
MNHV+!T,EG*O;MKTP0R[&2\U:R_/Z"\?-Y34N Q"(H0IKD=LODJ)CNABY7I2"
M9"CI 9+0L$B2W7=2BV:.(RNWC:=!MD85.Q1E763?&0(T'D6^*4@#&^Q7FYTF
M4YEK43! "G/'DKM152)L&ET%#9U )R'M)BW<?PI5(%*'1; "O,M T#[!'O$;
MD+[CQW=E+L X XUUF=/,ZT3=P<?6VR0AT7KE$*^W+*=.K43R29DPA64"?ITO
M;J0&*0^>,(6P"-S(@NOW1IU9>9V3D68[:7)#!19-IRL6-ZX$N>GTOD0]6K@#
ME*E VD3:LCL\$9PL$*"/4E*Z_^QD>46&B21-*'=N?+!R_][9FO47Y8%LXD*)
MTEE#XKI;BG(/S1%#S4>" 4$/,4</3H@U<%PTK%# A@\]_PBQD <@%F$> 2B"
M*T5L@6;'W09_"MT\Y;$]>'_QK+J[WIADF9D\E"= :H@G;XA1#V\ 0!@T!JV'
M*4\VPFO_ZG3;XF5Y%F.3(J$41Y83F5+GIC]9/6C6,;JATH8TH5B_V7"OJ[&
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MIK#P_@UO>B5A:Q%G*>*\WT[$J4+C59!>("P2EB@< >:@$0-_])!-.R )9A[
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MTL/J=O1I5:AQ(E]L#$#4(>.NBIN;QLF,457J.W)2'2I',5I!- ESQ.7EX79
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M@3B+/1:$2D_&'Z7Z[V"%Z'@AY'=4LCW,R+9N).DK2K,!72X.HHRI+@^.K_
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M=%SLC(6B?"K-N=SP:%>16$-68>_SW*R=%R?CJ;4D>I\ \8)T*PZP'1G9X#X
M9)GH8HDM2QKCZGQVSF\J,)5RN% A-9BSR^5;DNV4BZ/; YMDI,"0)M0^4SL?
M-^5R/,B;A"\XCKHP4V&8;2 /+[N=PSS!@UYH$*A?T=U  !L\*Y+K"A!(<VYH
M/,,L3A*\#8D(*,]JFH?R5]U&7EH-6,3]/U*T-1E1]%  T_D@[7I)R@3HIFM:
MNIZLTD[(+(.7]_54+G I"3EX=HMW-"$UE&"F-SH;'AX-E 5O.9PT:9X;KF'P
MX</@\*S;.?G@G'T:.+W1J'?\<? 9E.<5ZVFTV]PJ)AWL[3>8-^Y'\6U2=*ND
M$&OVEQ.-"W10&7NIE3D)U4M[A[N4GSS/K&1I770A!;E*J<'T=R;F*<GA,D6R
M-*IJF\E"1#R9Y)K1<TT![)T.*\LN',5A&[=.ZG1 6;"H!=MMY#R)<%+B@QF6
M-7?? BY^L'?@O ^XA +;W;<+S&2;4_+J"^T7H(Z2T82TP:S&9V"90D!>',O]
M49%KY3Y3E6IT[QJ9<:0S-8I9;?PW9<>AM.>=$X^N='XMQ;R7O"#6MP2%I, I
MG1^#\.*<BV5,\X1^\R84U8<8XY&BJ=4)J4(H'#))MZV-\L>ARE-6!8BA?L!*
MB'B3AVC]N!>D025;0R36.3(NCF+3E ;<T@@R57LA2P[!4XA-% 29,$(OF,DL
M:I,AE]Z_^/!TU:'_(/FA3F!HHN%W(C$\!8GAK,1$[P,>#U=091E!K-3W2R*A
MR'>1[(U%&%\5V#-"'.4?BQESTP+7-BYC)0H4DS:YU4>%H+(-C6UM;I6^-I+5
MUV4-J_4DKRC)O)V.Y%K ?-V&L*]UWWI3YF+EC\]7E$K83F @8E$NV:YKP0/#
M7%K5'?N!H<:3AUDP UT[7.@R,=K>2];Y$(W\_/?<"WQ3P(DK-TEZ6"E;7Y(N
MURTV3RW&5#$GOYQKJ7B^6Q21#9'%GY10815]D&/KG.2UI-4XZG:P7 J24]>J
MAK>S1.#@.-TUMDF: ;524[;URC(=CFFB@ !<:*+S33WU9$VER I 6(WO,]7'
MPEEZGUSPLC*0!1X4&^$MJ 1.36:/E=G:QC7]<.JTI>1)\BH*8R&_@:S&CK:.
MBFD!A,"=\2Y06A:3I (;>>R(L--R#%C*CJT2%30Q2,0LOM31[U:>1K.26XLX
MAMJ@W 6[!)B&OS%,"0"=:QKH^.BV?/QMMR]X>$"=UD*U)T&ZE=+^QE*:37(*
M'4@#T#G]@,6O)5',SH[%Q:N$2LI\NK!M4Q\?%/FHG^H:,M]R$0&^@3^K*Z$:
M%WK$9:+!KGM+TASUCY$FRN6B64 E0[GI V9[8J],S[+"UZ2)MI2\%5YN*+R8
M O)5$F !->E6$GP;:W:;&1A+EBL.[AJ:@]8Q&K0#U?^X 2\8=Z3X;ZD@U:T2
M;;(V1KZ*NIT5:, -A#@N.,IF-YV&2[0,]T,+L_4R7IV>T"8SYD),_0#ERJG:
M]>05J $D_:E;3;<37T6FIT!Q)76D"Z[.TBK5"LB6:X+/E[4;L"HA2/B-PS*T
MM#K:79"Y+:5S)> NTBTR9LM"VM6NZ;(40EL=]J%"\]+N7=L)KK:X[$TSF:C<
MK'R-6^6K5;XDO3J9L]?,DGB0P8)8 PI,;A$V]:#4Q,3WC"*&,C)-8P#U6(C(
MLE&3%8B3L(IF(->P;*EV;&:0IO"C9<[N*>6=I)3"*GLD['BF6OI(S$-OPAY6
MWJ1)/MS%[8*8!NL$R5(GL^B,;5T'\<^<:RNK.%$_-^$CQ99ZKI/$.>5P^]@O
M"=^YBJD^/>S'H:7 FF>HC,Y#JW&+F;HHY&F1,S:G7Y:E>%OKJ]65%:K =E"5
M0]%T"KO=#AUU5&X[,8>'[2?-!/G<#(]#J!E0>MLMG&K=F"D;#C;:*R6$F%.^
MR5U1^+@E??,*E*&4$TKGU-'*&$GWR+E/9?M1#/\^#S <:1)'G&TID[%\0/Y(
MRL9Z_R9-A%,X">S-BTK=D,!7A6[+@JN5.2D'-PU8V1SA%#FOT!F$#C.#RS*^
MCSH(T,4L70(GQI@+6+8$J_!"H6D!11THU0#3<("< _?#H.68ZCM/PT!FS=E#
M\!IX 7O.D+:!671TX7+Y8]5G\.7._MXSW6?PS/O>[6#*,38]6!@0E<!CD%3M
MU[2A+L6DH9H( $A9AC+RF U2$QD45AWH,D@RV]Z$V1#Q@G/@>F18 K)-79HX
M]Q:IJ!93.<P"5*&8NAL$4QU^YM:A&1ZJ?8'=C@0 Y5#E#)FH?G>:TL.E8'$Y
M(9T*W-0&,[I_8(,>A_OS-"."4R\WZ5OT8\&<C3OJ,([?X8J;"9K5H5>M=@_S
M5@@!BJ_141< .W:0K((@0)8/E?!I:I+8C)*Y((?=2&13N=>PR()@^>Q A\$>
MQCX&[M0B%-R^/F#V]L8S1"$R@YXAD.24>:*3*<KI: ?/=O9W=[S=51O&<L<1
M[Q2Y:%P$6\_Y>NIDWO>YM\!TS::U=CO%Q2(HSTQW-6H0)TFT?MG>4/&$GOS:
MLX]HCS+J_'B2$U#.$W$9Q'D*[PKD21QT504$BZTPT,JG:XPP^I<&.BPI!+!;
MW90\A2T79U]*OE'Z$'YK#_Y[VH-)T&A2%1A(&H5XRNVN1N99=I:"&J*].$H/
M&0O9N2$WD=-LF*Z3((#478EBDZ(U)437%FC<4A"NFJU$L6=1,,Y3K"HF:2K*
M&V[U^::C2ZUD4U7Q*8U)2HM)*.%,!4?U RAJ!%:V!N']DEGPYY4ZS4YOEP%W
MF1I22A%IGG/=8^]VBCK0SGMK%=<7TUL2]3>UY=K&CM'IUX*AHP9,X9%KVCA8
MY]\&&T?$#>RXB@@WSA&^U)+S"(/VSA,ODJ57E&\8UU1K"X&32&U+2*F[I:0$
ME+S5; QQ[M060JG@X8("R//"M:]-=]8W?FCWNK1^N#HSR)[V=HT Y'^<9QO8
M *Q%W<P   .PG4=6-2AI_ZW?XR%2_E]K*?]R&EXBM->GZ6N>Q3M2PII-2DC4
MM\^<9*MV:!%>H=N5:<7--3L:J4:O*T_<3!18I[N^1<PI&\0L[=F0:IIK8W.8
M&J79%M8*?#]8X-O2JI(-.JFF$K>ND)+$^'-JHT6Z(#71;N<V55&>X@[UT.L(
M@R79L]MIE="MIDG;3))4$/)J%;3_<ZB@OJJ9<5,%M+^6 EK5Q+9/ >W?CP+:
MWT8%M+^I MI?KH NU17Z6Z\K-+N!3![#K>D*_1OH"OT?HRO4.<_[+.3KC=]0
M5^BWNL)]\^5MM@W7,N ?I"OT?UY=H?_C=87^7>L*U^';K:[PT&C2-A.E@R?[
M+Q04_H>*T64WT F:(F^-8>Y.0F^O> --4;<HXSOPE=SG9M&W*^3];N?NHV_E
MOM96 -8,HKU6=*SF0"L7TSIP'B(EW'('S@\)NG;6B2)W=JA:J5)**.*U$ ,+
MVG X4<&&\#*@?LJ!?86P5X4W7/5;HAMA/M.X::+$0C1-V(@J2\D7J4B1@)5%
M'UO?4A.;)-";!>=KXT -:ZFS$G0[]QNL7EK:-6T%-9MT&FT&ZWGKO-I!;T4/
M5X-=4Q6O'M'R<,PVK^OV9,<M%1Y+B>MUN.X6TM$+<'P-?1>KH]L*;UE6W6(E
M5VUY&*'Q*)<4>MFCMQN/61G[AVFTY9E:5?:G)$?!]^TD1LMPSF+K5!>'6J*0
M91V1Z!S."YDI<D(OB+*%;/G %3NL0AQ A+H=J\9#$7U14T5_C$[[:# DZ[6
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M.9$TS%@GZXP5]?),R0%!AB*S0D-@:AB66V6$3ID/(F=4C+":1;+F1$LY8Z7
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MNHG)>A=7*\UN+Y?*X6.__@%02P,$%     @ (*U34O?_'-V0!@  _T8  !4
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M0=KY-TD!40Y028AFWE9*-\RYA^O/[KA66_I/NB2[>/R'3=2>_P%02P,$%
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M&YQYMAV(ZPOMB&$+[W]X[>4R.$C*K2XP;]WNCI@O\PZI+OD'4$L! A0#%
M  @ (*U34J +]<"G'0  R9<   T              ( !     &0V-#,W-V0X
M:RYH=&U02P$"% ,4    "  @K5-2H4ZSDL5(   P-@( #P
M@ '2'0  9#8T,S<W9&5X,C$N:'1M4$L! A0#%     @ (*U34@$7HU<= P
MQ0H  !$              ( !Q&8  '1L<GDM,C R,3 R,3DN>'-D4$L! A0#
M%     @ (*U34O?_'-V0!@  _T8  !4              ( !$&H  '1L<GDM
M,C R,3 R,3E?;&%B+GAM;%!+ 0(4 Q0    ( ""M4U*">I<6MP0  *(L   5
M              "  =-P  !T;')Y+3(P,C$P,C$Y7W!R92YX;6Q02P4&
/  4 !0 ] 0  O74

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
